News

As non-surgical aesthetic procedures continue to grow, so do the number of medical spas that perform cosmetic treatments. According to Dr. Renato Saltz, that’s not necessarily a bad thing.

According to Dr. Gary Linkov, effectively evaluating hair loss in women requires a strategic approach and comprehensive patient consultation.

CBD is taking the market by storm, but does it offer benefits to the skin itself? With their new line of CBD skincare and wellness products, Dermaquest says yes.

David J. Goldberg, M.D., discusses what constitutes wrongful termination in this Legal Eagle article.

Oculoplastic surgeon William Mack, M.D., says identifying and surgically correcting (or referring) ptosis in cosmetic blepharoplasty patients is key to delivering optimal results.

According to Dr. Michael Somenek, the key to great results and happy male patients is knowing how to treat his face without feminizing his features.

To recognize Antibiotic Awareness Week, we’ve gathered articles on antibiotic use in acne, alternative therapies and treatment trends in the specialty. View the highlights in this slideshow.

Instagram and Snapchat may be detrimental to young people’s mental health. But can (and should) Instagram shield youth from cosmetic surgery procedure posts?

Dr. Wever discusses the prevalence of BDD in the aesthetic practice and how to identify the psychological disorder.

By the end of a three-day weekend, five of the teams at Hacking Dermatology's 2019 Hackathon walked away with $5,000 each. Learn more about the collaboration that took place and the solutions each team developed to solve pressing problem areas in dermatology.

Brett Coldiron, M.D., offers insight on how recent legislative and regulatory changes may impact your practice.

Stay up-to-date on the most recent clinical advances in atopic dermatitis.

The appointment of Mary Lynn Moran, M.D., F.A.C.S., as the first female president of AAFPRS suggests growth in female access to leadership roles in the medical aesthetics industry.

In this month's Innovation article, Steve Xu, M.D., FAAD, highlights a company and innovator who are using artificial intelligence to augment physician decision-making, not replace it. ƒ

Dr. Chilukuri discusses how to create a smooth and prosperous transition for that new device into your practice.

Two physicians talk over-filled lips – why they happen and tips for more natural treatment results. 

Connell announces exclusive distribution agreement for Asia-Pacific with biodesign company, Geltor, known for its 100% animal- and GMO-free proteins.

Drug development in acne is currently focused on targeting inflammation and reworking the vehicles of existing active drugs to increase their efficacy and tolerability, according to this expert. 

If the public pays for the training of physicians, can it be argued that the public has an ownership property interest in American healthcare? David J. Goldberg, M.D., J.D., provides his insight.

Interleukin-29 (IL-29) is a newly discovered cytokine that has become the subject of increased research attention for its role in inflammation and inflammatory autoimmune disorders and therefore as a target for novel therapeutic development.

Clascoterone 1% cream is in late stage development for acne treatment and in a higher strength solution for androgenetic alopecia. Read more about this novel treatment here.

Drs. Lilit Garibyan, Steve Xu and Kachiu C. Lee highlight a grassroots initiative that encourages physicians to become more involved in innovation in dermatology.

To recognize the one year anniversary of our Innovation column, the Dermatology Times Staff has compiled key takeaways from topics covered throughout the year. View them in this slideshow.

Another neurotoxin is in the pipeline, but will this one fill an unmet need? Dr. Joel Cohen explains.

A recent study examines the surgical time and financial savings when using 3D-printed models and surgical guides.

Hilary Baldwin, M.D., discusses the nuances of adult female acne and its treatments in her presentation at the Fall Clinical Dermatology Conference in Las Vegas.

Radiodermatitis affects approximately 95% of all patients who receive radiation therapy for cancer - many of who are women undergoing breast cancer treatment. A recent study has found that developing the condition has a significant and detrimental impact on breast cancer patients' overall quality-of-life.

What were the treatment trends of 2018 according to ASDS research? Joely Kaufman, M.D., chair of the ASDS survey work group, explains.